Argitalpenak: 2006
-
Imidazoline I(2) receptors as a possible marker for malignancy in human glial cell tumours Revista de Neurología, 2006; 43(8), 476 - 480
-
Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites Bioorganic & Medicinal Chemistry, 2006; 14(19), 6570 - 6580
-
Pharmacological characterization and autoradiographic distribution of alpha2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain Neuroscience, 2006; 141(1), 357 - 369
-
Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates Neuroscience, 2006; 140(2), 635 - 643
-
Levels of G-protein alpha q/11 subunits and of phospholipase C-beta(1-4), -gamma, and -delta1 isoforms in postmortem human brain caudate and cortical membranes: potential functional implications Neurochemistry International, 2006; 49(1), 72 - 79
-
The N251K functional polymorphism in the alpha(2A)-adrenoceptor gene is not associated with depression: a study in suicide completers Psychopharmacology (Berl)., 2006; 184(1), 82 - 86
-
Heterotrimeric G proteins: insights into the neurobiology of mood disorders Current Neuropharmacology, 2006; 4(2), 127 - 138
-
Imidazoline I(2) receptors as a possible marker for malignancy in human glial cell tumours Revista de Neurología, 2006; 43(8), 476 - 480